Parallel with the expression of S100A8 and S100A9 IMQ-treated mice developed psoriasis features like erythema, scaling, thickening of skin, parakeratosis, acanthosis of the epidermis, signs of hyperproliferation of keratinocytes, and increased numbers of basal keratinocytes. Here, S100A8 is linked to psoriasis.